🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 60 of 200 · A–Z by INN

  1. doxylamine succinate

    DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE Quantum Biopharma

    ORAL FDA: approved

  2. dressing hydrocolloid cavity wound

    DUODERM PASTE 187930

    TGA: approved

  3. dressing hydrogel amorphous

    SOLOSITE GEL 36361338

    TGA: approved

  4. dried recombinant herpes zoster vaccine (derived from chinese hamster ovary cells)

    SHINGRIX

    PMDA: approved

  5. dromostanolone propionate

    DROLBAN

    INJECTION FDA: approved

  6. dronabinol

    MARINOL

    ORAL FDA: approved

  7. dronedarone

    MULTAQ Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved

    C01BD07

  8. dronedarone hydrochloride

    DRONEDARONE HYDROCHLORIDE

    ORAL FDA: approved

  9. droperidol

    DROPERIDOL Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  10. drospirenone

    LUCINDA

    ORAL-28 FDA: approved · TGA: approved

  11. drospirenone + ethinylestradiol

    YAZ Lacuna Pharma Pty Ltd

    TGA: approved

  12. drotrecogin alfa (activated)

    XIGRIS

    EMA: withdrawn

    B01AD10

  13. droxidopa

    DROXIDOPA Teva Pharma GmbH

    ORAL FDA: approved

  14. dry aqueous extract of paullinia cupana seed

    CINAINU

    EMA: application withdrawn

  15. dtcp-hib-

    NMPA: clinical trials

  16. dual-car-t

    NMPA: clinical trials

  17. dual-target

    NMPA: clinical trials

  18. dulaglutide

    TRULICITY

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    A10BJ05

  19. duloxetine

    APO-DULOXETINE Alphapharm Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    N06AX21

  20. duloxetine hydrochloride

    CYMBALTA PARTIAL CHANGE APPROVAL Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ORAL FDA: approved · PMDA: approved

  21. duloxetine hydrochloride 20 mg oral capsule, delayed release

    NMPA: clinical trials

  22. dupilumab

    DUPIXENT Sanofi-aventis Healthcare Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    D11AH05

  23. dupixent

    NMPA: clinical trials

  24. durlobactam sodium

    XACDURO (COPACKAGED)

    INTRAVENOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources